Schofield, Pamela Jean,Berg, Henry Van den,Burgio, David Ernest,Chines, Arkadi Aaron
申请号：
NO20043113
公开号：
NO340249B1
申请日:
2004.07.20
申请国别(地区):
NO
年份:
2017
代理人:
摘要：
A method comprising orally administering to a human or other mammal a pharmaceutical composition comprising from about 65% to about 110% of the cumulative effective dose of risedronate or a pharmaceutically acceptable acid, salt, ester, solvate, or polymorph thereof according to a continuous dosing schedule of one, two, or three consecutive days per month is useful for treating or preventing osteoporosis and other bone metabolic disorders.
